A study of people in Brazil with IDH-mutant diffuse glioma
Original title: A Single-arm Observational Study to Characterize the Epidemiological Profile of Patients With IDH-mutant Diffuse Gliomas Diagnosed From 2021 in Brazil.
How far along is this research?
This is a trial that is enrolling or has been updated. It is not a finding yet.
No phase is given for this study, and it collects records rather than testing a treatment.
Status: Not yet recruiting. It has not opened yet. Ask your care team to watch for it if it looks like a fit.
The trial team last updated this record on . Always check the trial page for the latest.
The short version
This study looks back at the health records of people in Brazil who have a brain tumor called IDH gene change: A small change in a tumor's IDH gene. Tumors with this change often grow more slowly and may respond to different treatments. Your pathology report says whether your tumor has it. See the glossary diffuse glioma: A tumor that starts in the glial cells, the support cells of the brain and spinal cord. Gliomas are graded 1 to 4 by how fast they tend to grow. See the glossary.
Who this trial is for. This study is for people in Brazil who were found to have an IDH gene change: A small change in a tumor's IDH gene. Tumors with this change often grow more slowly and may respond to different treatments. Your pathology report says whether your tumor has it. See the glossary diffuse glioma: A tumor that starts in the glial cells, the support cells of the brain and spinal cord. Gliomas are graded 1 to 4 by how fast they tend to grow. See the glossary starting in 2021. It is not testing a drug. Site staff would collect information from patients' medical charts.
Where it stands. The study is meant to build a picture of who these patients are. It has not reported any findings. Care choices stay with each patient's own doctor, and no extra visits are asked for.
What this means, and what it doesn't
What it could mean: This study does not offer a new treatment. Someone who fits the group could ask their care team about it.
What it doesn't mean: This does not mean a new treatment works. A study is a test, not proven care. Taking part does not promise any benefit. It is not a promise of a cure.
Source: ClinicalTrials.gov, August 27, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.